MedPath

Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter

Not Applicable
Completed
Conditions
Renal Failure Chronic
Interventions
Device: Hemodiafilter
Device: Fresenius Medical Care AG & Co.KGaA
First Posted Date
2024-06-12
Last Posted Date
2024-06-12
Lead Sponsor
Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd
Target Recruit Count
160
Registration Number
NCT06454981
Locations
🇨🇳

Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath